A convergence of global epidemics: diabetes as a modulator of neurodegenerative and neuro-inflammatory disorders - Top-Institutions - MDSpire

A convergence of global epidemics: diabetes as a modulator of neurodegenerative and neuro-inflammatory disorders

  • By

  • Louisa Leone

  • Tighe J. Kiernan

  • Satoshi Kuwabara

  • Michael Barnett

  • Emma Devenney

  • Rebekah M. Ahmed

  • Cindy Shin-Yi Lin

  • June 18, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    University of California, San Francisco
    University of California, San Francisco

    San Francisco, California

    Key Differentiators

    • Neurology
    • Diabetes Research

  • #2

    Johns Hopkins Medicine
    Johns Hopkins Medicine

    Baltimore, Maryland

    Key Differentiators

    • Neurology
    • Diabetes Research

Original Source(s)

A convergence of global epidemics: diabetes as a modulator of neurodegenerative and neuro-inflammatory disorders

  • by Louisa Leone, Tighe J. Kiernan, Satoshi Kuwabara, Michael Barnett, Emma Devenney, Rebekah M. Ahmed, Cindy Shin-Yi Lin

  • June 18, 2026

Related Content

Oculomics: Beyond the Buzzword

Joseph J. Pizzimenti, OD, FAAO, FORS, discusses the capabilities of oculomics in retina and neuro-ophthalmology,

Adaptive deep brain stimulation for dynamic gait control in Parkinson’s disease: a randomized feasibility trial

Peripheral B cell immune dysregulation genetically contributes to stage-dependent neuroinflammation and identifies priority therapeutic targets in Parkinson’s disease: a computational integration of Mendelian randomization and single-cell transcriptomics